Biological Defense Measures Market, Global Outlook and Forecast 2023-2032
Biological Defense Measure is a set of medical or military measures. These are taken in response to the demand for restoring the biosecurity of a country against biological toxins or infectious agents. The agents can be used with the intent to kill or infect humans, animals, or the environment and to instigate biological warfare. Biological agents used during bioterrorism are usually living organisms. These can include bacteria, viruses, fungi, or toxins that are deliberately used to sicken and kill creating social and economic turmoil.
This report aims to provide a comprehensive presentation of the global market for Biological Defense Measures, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Defense Measures. This report contains market size and forecasts of Biological Defense Measures in global, including the following market information:
Global Biological Defense Measures Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Biological Defense Measures market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biological Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biological Defense Measures include Alnylam Pharmaceuticals Inc, Aeolus Pharmaceuticals, Achaogen, Arbutus Biopharma, Altimmune Inc, Bavarian Nordic, Cleveland Biolabs, Emergent Biosolutions Inc and Elusys Therapeutics Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biological Defense Measures companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Defense Measures Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Biological Defense Measures Market Segment Percentages, by Type, 2022 (%)
Biological
Chemical
Radiological
Nuclear (CBRN) Warfare Agents
Others
Global Biological Defense Measures Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Biological Defense Measures Market Segment Percentages, by Application, 2022 (%)
Medical
Military
Global Biological Defense Measures Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Biological Defense Measures Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biological Defense Measures revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biological Defense Measures revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals Inc
Aeolus Pharmaceuticals
Achaogen
Arbutus Biopharma
Altimmune Inc
Bavarian Nordic
Cleveland Biolabs
Emergent Biosolutions Inc
Elusys Therapeutics Inc
Dynport Vaccine Company
Dynavax Technologies Corporation
Hytest
Ichor Medical Systems
GSK
SIGA Technologies
Sanofi
Soligenix
Ology Bioservices
PharmAthene
Xoma Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Defense Measures, market overview.
Chapter 2: Global Biological Defense Measures market size in revenue.
Chapter 3: Detailed analysis of Biological Defense Measures company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Defense Measures in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
